In September 2025, Ukraine’s pharmaceutical industry reached several important milestones: from strengthening control and raising standards to truly expanding access to medicines. These steps are not just operational changes, but signals of industry renewal. Here’s what you need to know.
On September 18, 2025, a meeting of the constituent assembly was held, which laid the foundation for the creation of the National Organization for the Verification of Medicinal Products (NOVL) in Ukraine.
This is a key victory: a concept that has been discussed for a long time is being implemented. Through this organization, medicines will be labeled with a two-dimensional code, tracked in the supply chain, and the risk of counterfeiting will be reduced.
Why is this important:
As of September 30, 2025, the Ministry of Health of Ukraine has expanded the “Affordable Medicines” program, adding 85 new drugs. The list includes drugs for pregnant women and mothers, thyroid, glaucoma, childhood diseases, cardiovascular, respiratory, metabolic, and neuropsychiatric disorders.
What does this mean:
On September 25, a webinar was held entitled “180 Days of New Regulation of Drug Prices. Results, Prospects, and Practical Recommendations.” The following topics were discussed: impact on the market, problems with filling out the National Price Catalog, calculation of the maximum wholesale selling price, and the difference between catalog prices and registration prices.
Main alarm signals:
On September 18, the Chairman of the Verkhovna Rada Committee on Health Care, Mykhailo Radutsky, emphasized that when adapting the Critical Medicines Act to Ukrainian legislation, Ukraine must take into account its own production potential of active pharmaceutical ingredients (API).
This is strategically important: Ukrainian pharma can become a player in the European market.
Key points:
September 2025 is a month of transformations, not just news. Ukrainian pharmaceutical system:
Those who work in the pharmaceutical sector — from manufacturers to pharmacists — now have the chance to be not just participants, but co-authors of change.
Growing organic raspberries is always a balancing act between agronomy, climate, and soil biology. These factors were particularly acute in the 2024–2025 season, as weather conditions in central Ukraine were unstable and stressful for the crop.
The AVELIFE Institute of Nanotechnology and Organic Products is developing the direction of nanocellulose as a qualitatively different level of cellulose materials — not just a crushed, but a structurally reinterpreted form of a natural biopolymer.
If you look at organic farming more closely, it ceases to be a marketing label and opens up as a different logic of interaction with the soil. It feels like you are moving from a primitive game of fertilizer to a real strategy for managing a natural system, where the soil is a partner, not an object of influence.
